623-58-5
623-58-5
Chemical Structure
Acetoacetic acid sodium
- CAS 番号: 623-58-5
- Formula:C4H5NaO3
- Molecular Weight:124.07
IUPAC Name: sodium 3-oxobutanoate
InChIKey: UAKCMIIOSJFOTD-UHFFFAOYSA-M
SMILES: CC(CC(O[Na])=O)=O
Biological Activity: Acetoacetic acid sodium is an oxidative stress inducer that affects the antioxidant enzyme system and lipoprotein metabolism. Acetoacetic acid sodium induces oxidative stress by decreasing the mRNA expression and activity of superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GSH-Px), increasing MDA content, and inhibiting very low density lipoprotein (VLDL) assembly by downregulating apolipoprotein ApoB100, ApoE, and low density lipoprotein receptor (LDLR), leading to triglyceride (TG) accumulation in hepatocytes. Acetoacetic acid sodium can be used to study metabolic diseases[1][2][3].
| 製品番号 | 製品名 | 純度 | 製品説明 | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Acetoacetic acid sodium | 98.0% | Acetoacetic acid sodium is an oxidative stress inducer that affects the antioxidant enzyme system and lipoprotein metabolism. Acetoacetic acid sodium induces oxidative stress by decreasing the mRNA expression and activity of superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GSH-Px), increasing MDA content, and inhibiting very low density lipoprotein (VLDL) assembly by downregulating apolipoprotein ApoB100, ApoE, and low density lipoprotein receptor (LDLR), leading to triglyceride (TG) accumulation in hepatocytes. Acetoacetic acid sodium can be used to study metabolic diseases. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Acetoacetic acid lithium | 98.0% | Acetoacetic acid lithium is an oxidative stress inducer that affects the antioxidant enzyme system and lipoprotein metabolism. Acetoacetic acid lithium induces oxidative stress by decreasing the mRNA expression and activity of superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GSH-Px), increasing MDA content, and inhibiting very low density lipoprotein (VLDL) assembly by downregulating apolipoprotein ApoB100, ApoE, and low density lipoprotein receptor (LDLR), leading to triglyceride (TG) accumulation in hepatocytes. Acetoacetic acid lithium can be used to study metabolic diseases. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Sodium 2-oxobutanoate-13C4 | 99.5% | Sodium 2-oxobutanoate-13C4 is the 13C labeled Sodium 2-oxobutanoate. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Pyruvic acid sodium | 99.86% | Sodium 2-oxopropanoate (Sodium pyruvate), a three-carbon metabolite of Glucose, is a compound produced in the glycolytic pathway. Sodium 2-oxopropanoate is a free radical scavenger that can scavenge ROS. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Pyruvic acid-13C3 sodium | 99.61% | Sodium 2-oxopropanoate-13C3 is the 13C-labeled Sodium 2-oxopropanoate. Sodium 2-oxopropanoate (Sodium pyruvate), a three-carbon metabolite of Glucose, is a compound produced in the glycolytic pathway. Sodium 2-oxopropanoate is a free radical scavenger that can scavenge ROS. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Pyruvic acid-13C-1 sodium | 98.90% | Sodium 2-oxopropanoate-13C is the 13C labeled Sodium 2-oxopropanoate. Sodium 2-oxopropanoate (Sodium pyruvate), a three-carbon metabolite of Glucose, is a compound produced in the glycolytic pathway. Sodium 2-oxopropanoate is a free radical scavenger that can scavenge ROS. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Pyruvic acid-13C2-1 sodium | 99.0% | 2-Oxopropanoate-13C2 (sodium) is the 13C labeled Sodium 2-oxopropanoate. Sodium 2-oxopropanoate (Sodium pyruvate), a three-carbon metabolite of Glucose, is a compound produced in the glycolytic pathway. Sodium 2-oxopropanoate is a free radical scavenger that can scavenge ROS. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Pyruvic acid-13C sodium | 99.18% | Pyruvic acid-13C (sodium) is the 13C-labeled Pyruvic acid. Pyruvic acid is an intermediate metabolite in the metabolism of carbohydrates, proteins, and fats. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Pyruvic acid-1-13C-2 sodium | 99% | Pyruvic acid-13C-2 (sodium) is the 13C labeled Pyruvic acid. Pyruvic acid is an intermediate metabolite in the metabolism of carbohydrates, proteins, and fats. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Methyl acetylacetate | 99.86% | Methyl acetylacetate is a chemical reagent used in the synthesis of pharmaceuticals for the synthesis of α-substituted acetoacetate and cyclic compounds such as pyrazole, pyrimidine, and coumarin derivatives. Methyl acetoacetate can be used in the study of inflammatory diseases. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Methyl acetylacetate-13C4 | Methyl acetylacetate-13C4 is an isotopically labeled compound. Methyl acetylacetate-13C4 can be used for various biochemical studies. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
